This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The ongoing patent litigation between CureVac and Pfizer /BioNTech will move to a court in Virginia following a request from Curevac, potentially bringing forward the trial date to sometime in 2024. The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly.
Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.
They hope to gut a data program and slash HIV funds in the 2024 budget, but they also asked questions about the breadth of the agency’s portfolio outside of communicable diseases. Read the rest…
The strain on pharmacists can lead to errors, as evidenced by a pharmacist who almost administered the wrong vaccine dosage due to workload pressures. A cultural shift within the profession is also needed, encouraging open communication and prioritizing self-care to create a supportive environment for pharmacists.
On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. Novavax won’t disclose its revenue until later this month, but its latest communications don’t exactly inspire confidence.
The company aims to then increase supplies in 2024. Common treatment options for the condition include bladder removal surgery, chemotherapy and/or administration of the BCG vaccine in the bladder. Ferring plans to begin Adstiladrin production in the H2 2023, as part of an initial rollout in the US.
Developments such as mRNA cancer vaccines , pharmacogenomics and personalised medicine are going to be transformative for the sector, Professor Meier says. And he draws a parallel to the Covid-19 pandemic when pharmacists played a central role when carrying out vaccinations, even in countries where this was previously unprecedented.
Artificial intelligence can assist governments and healthcare institutions in combating pandemics , including monitoring and predicting outbreaks, speeding up diagnostics and research, repurposing existing drugs, and even accelerating vaccine design and development. AI in life sciences is a lot more than just a tool for optimization.
As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.
This guest blog is one in a series by sponsors of the 2024 PQA Annual Meeting on a survey which highlights opportunities for pharmacies and payers to boost medication compliance. As pharmacies evolve and embrace digital communications, patient preferences are evolving, too. It can also improve patient satisfaction.
Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. How can these issues be addressed?
After finishing his degree here, he undertook his pre-registration in a busy community pharmacy in a deprived area of east London. One of the most valuable lessons he learnt from this experience was the importance of communication. ‘As million residents of Hong Kong. But that was not all.
In this blog, we will explore what pharmacies should know about the recent surge in COVID-19, the co-occurrence of Flu and RSV, and the significance of vaccinations and testing in controlling these infections. Vaccinating For Respiratory Viruses in 2023 Vaccination remains the most potent tool in combating severe illness from these viruses.
With hundreds of invited speakers, the ESCMID Global 2024 gathering in Barcelona, Spain (27-30 April), welcomed approximately 16,000 delegates for five days of knowledge exchange, collaboration and innovation. The post Highlights from ESCMID Global 2024: AI, climate change and AMR appeared first on Hospital Pharmacy Europe.
To support pharmacists’ ability to assess patients’ immunization needs and successfully close gaps in care related to vaccinations, immunization authority should be consistent across states and pharmacy practice sites.
In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. billion in Covid-19 vaccine sales.
Although I have practiced in the area of infectious diseases pharmacy for quite a while now, measles has not been of much clinical relevance to me beyond MMR for routine vaccination. Vaccination is the best way to prevent measles This is an obvious one, but necessary to state right out the gate. MMR is given in 2 doses.
Educate on Vaccinations & Heart Disease According to the American Heart Association , viral diseases like COVID-19, influenza, and respiratory syncytial virus (RSV), as well as bacterial infections such as pneumonia, can induce inflammation thus increasing a patients risk of a heart attack or stroke.
of the newly combined company The combined companies’ focus is to advance Elicio’s lymph node-targeting amphiphile technology to develop immunotherapies & also focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors is currently being evaluated in the P-I trial (AMPLIFY-201) for PDAC and CRC.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content